Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q7809768> ?p ?o }
Showing triples 1 to 34 of
34
with 100 triples per page.
- Q7809768 subject Q6762709.
- Q7809768 subject Q8401092.
- Q7809768 subject Q8760194.
- Q7809768 abstract "Titan Pharmaceuticals, Inc. is a California biopharmaceutical company developing proprietary therapeutics primarily for the treatment of central nervous system ("CNS") disorders.Titan's principal asset is Probuphine, a slow-release implant formulation of buprenorphine hydrochloride (“buprenorphine”) for the treatment of opioid addiction or chronic pain. Template:As of 2015, it was in phase 3 trials.".
- Q7809768 industry Q12140.
- Q7809768 location Q99.
- Q7809768 numberOfEmployees "13".
- Q7809768 type Q891723.
- Q7809768 wikiPageExternalLink www.titanpharm.com.
- Q7809768 wikiPageWikiLink Q12140.
- Q7809768 wikiPageWikiLink Q6762709.
- Q7809768 wikiPageWikiLink Q7180990.
- Q7809768 wikiPageWikiLink Q8401092.
- Q7809768 wikiPageWikiLink Q8760194.
- Q7809768 wikiPageWikiLink Q891723.
- Q7809768 wikiPageWikiLink Q99.
- Q7809768 homepage www.titanpharm.com.
- Q7809768 industry Q12140.
- Q7809768 location Q99.
- Q7809768 name "Titan Pharmaceuticals".
- Q7809768 numEmployees "13".
- Q7809768 type Q891723.
- Q7809768 type Organization.
- Q7809768 type Agent.
- Q7809768 type Company.
- Q7809768 type Organisation.
- Q7809768 type Agent.
- Q7809768 type SocialPerson.
- Q7809768 type Thing.
- Q7809768 type Q43229.
- Q7809768 comment "Titan Pharmaceuticals, Inc. is a California biopharmaceutical company developing proprietary therapeutics primarily for the treatment of central nervous system ("CNS") disorders.Titan's principal asset is Probuphine, a slow-release implant formulation of buprenorphine hydrochloride (“buprenorphine”) for the treatment of opioid addiction or chronic pain. Template:As of 2015, it was in phase 3 trials.".
- Q7809768 label "Titan Pharmaceuticals".
- Q7809768 homepage www.titanpharm.com.
- Q7809768 name "Titan Pharmaceuticals".